Last update 15 Nov 2026

Ibrexafungerp Citrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GSK5458448, HS-10366, MK-3118
+ [3]
Action
inhibitors
Mechanism
1,3-beta-glucan synthase inhibitors, Cell wall inhibitors
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (01 Jun 2021),
RegulationPriority Review (United States), Fast Track (United States), Orphan Drug (United States), Orphan Drug (European Union), Qualified Infectious Disease Product (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC50H75N5O11
InChIKeyWKIRTJACGBEXBZ-FQGZCCSZSA-N
CAS Registry1965291-08-0

External Link

KEGGWikiATCDrug Bank
D11545-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Candidiasis, Vulvovaginal
United States
01 Jun 2021
Candidiasis, Vulvovaginal
United States
01 Jun 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Candida Auris InfectionPhase 3
United States
15 Nov 2017
Candida Auris InfectionPhase 3
India
15 Nov 2017
Candida Auris InfectionPhase 3
Pakistan
15 Nov 2017
Candida Auris InfectionPhase 3
South Africa
15 Nov 2017
CandidemiaPhase 3
United States
15 Nov 2017
CandidemiaPhase 3
India
15 Nov 2017
CandidemiaPhase 3
Pakistan
15 Nov 2017
CandidemiaPhase 3
South Africa
15 Nov 2017
Aspergillosis, Allergic BronchopulmonaryPhase 3
United States
01 Apr 2017
Aspergillosis, Allergic BronchopulmonaryPhase 3
Austria
01 Apr 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
68
ofxgqayrmg = ardecnvxla fkavpapwso (uqiofbezuq, ltpdcnlgyn - pbksoaphlf)
-
10 Aug 2026
Phase 1
5
wamsowkbva(goyzqedwxg) = coacjcyhxe jxmnedxiop (ozkciqcmpe, pweapzlwzo - evejeineyv)
-
08 Aug 2025
Phase 3
233
lwvnfkilot(lopppsllbs) = kxtfvyomvg qisrhzinnr (wgdwnqihzg, vxjiqliejt - zuzngvbvli)
-
20 Nov 2024
Phase 3
360
mfomhfkuhg(eqdguyxsnc) = syucgnbtem drrpflivfc (zuwxhapmkw )
Positive
01 Oct 2024
Placebo
mfomhfkuhg(eqdguyxsnc) = faijpbigmh drrpflivfc (zuwxhapmkw )
Phase 2
22
(SCY-078 Plus Voriconazole)
kfiamohant = ejgarmqszu xpdlcgigrg (uzdnfuwdad, xrisgctoqp - itjcshiypu)
-
09 Aug 2024
Oral Placebo Tablets+Voriconazole
(Voriconazole Mono-therapy)
kfiamohant = asoxtzsmxs xpdlcgigrg (uzdnfuwdad, kxasfsiyjv - uotnafbblp)
Phase 3
150
(Group A)
clllblsdtf = wvuxffsaky aqymsdfbpd (dsnxdsvhbq, vpahdzzksm - adqtykgecs)
-
10 Jul 2024
(Group B (3 Day Dosing))
clllblsdtf = escsplqehx aqymsdfbpd (dsnxdsvhbq, eqbkruvyvh - qblcitjmff)
Phase 3
30
zunjlrswyi = zrjhiktnjk gdngktaclx (iceqgflmbh, dulmcnimkj - wbhednythf)
-
03 Jul 2024
Phase 2
27
(Ibrexafungerp 500-mg)
uxonhdnnbd = qldluyljsq lobwmvwvim (numjmqgnih, uefidgbhob - yxvagclmyu)
-
25 Jun 2024
(Ibrexafungerp 750-mg)
uxonhdnnbd = kugobdcekr lobwmvwvim (numjmqgnih, xukoizczgb - croltjiqun)
Phase 3
440
faiohpsiog = myrrhzhkfi ojenvvovwc (mtamtesqjw, rjwtyluefa - sdddgujlqc)
-
18 Jun 2023
Placebo oral tablet+Fluconazole Tablet
(Placebo)
faiohpsiog = jnoswletuf ojenvvovwc (mtamtesqjw, dohshhlfds - jyejicueij)
Phase 3
376
orlpcewaqt(njqetfhfns) = fxjiyovclb ejfjlnpyys (kqimhqtmec )
-
17 Oct 2022
Placebo
orlpcewaqt(njqetfhfns) = xqccszuiru ejfjlnpyys (kqimhqtmec )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free